EU approves expanded daratumumab indication for myeloma

Genmab and Janssen have announced that the European Commission has granted full approval for daratumumab (Darzalex®) to be used in combination with lenalidomide (Revlimid®) and dexamethasone, or bortezomib (Velcade®) and dexamethasome as a treatment for relapsed and/or refractory myeloma patients. This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use’s (CHMP)…

Details

Plasma Cell Leukaemia

This Infosheet is written for patients and explains:

  • What plasma cell leukaemia is
  • The most common symptoms and complications associated with it
  • How it is diagnosed, treated and managed
  • What the likely prognosis is

POEMS syndrome

This Infosheet is written for patients and explains:

  • What POEMS syndrome is
  • The most common symptoms associated with it
  • How it is diagnosed, treated and managed

Solitary Plasmacytoma Infosheet

This Infosheet is written for patients and explains:

  • What a solitary plasmacytoma is
  • The signs and symptoms associated with it
  • How it is diagnosed and treated
  • What happens after treatment

Living With Myeloma: Your Essential Guide

This Infoguide is written for patients. It aims to provide:

  • A better understanding of myeloma and the impact it may have
  • Ways to manage some of the challenges brought about by a diagnosis of myeloma
  • Tips on how to cope with the symptoms and complications of myeloma and side-effects of treatment

Ixazomib (Ninlaro®) Infosheet

This Infosheet is written for patients and explains:

  • What Ninlaro (ixazomib) is and how it works
  • How it is used in myeloma patients
  • The possible side-effects associated with it
  • What evidence exists for its use as a treatment for myeloma

Steroids Infosheet

This Infosheet is written for Al amyloidosis patients. It aims to:

  • Provide information about steroids and why they are used in the treatment of AL amyloidosis
  • Explain the possible side-effects associated with them
  • Help patients make informed decisions about their treatment options

Bendamustine Infosheet

This infosheet is written for patients and explains:

  • What bendamustine is and how it works
  • How it is used to treat myeloma patients
  • The possible side-effects associated with it

Kyprolis® (carfilzomib) Infosheet

This Infosheet is written for patients and explains:

  • What Kyprolis (carfilzomib) is and how it works
  • How it is used to treat myeloma
  • The possible side-effects associated with it
  • What evidence exists for its use as a treatment for myeloma